Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc.

XENE | NASDAQ
Chart Builder DCF Calculator
$38.72
-$0.27 (-0.69%)
Sep 22, 2026, 1:20 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
199.16M 142.71M 148.64M 57.24M 175.69M 45.01M
Short-Term Investments
349.72M 484.19M 489.44M 534.85M 376.09M 131.99M
Long-Term Investments
37.15M 127.5M 292.79M 128.68M n/a n/a
Other Long-Term Assets
7.15M 7.5M 7.4M 7.75M n/a n/a
Receivables
1.37M 1.47M 874K 986K 2.77M 1.82M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
10.39M 6.89M 6.01M 7.23M n/a n/a
Total Current Assets
560.65M 635.26M 644.96M 600.3M 559.02M 181.78M
Property-Plant & Equipment
15.35M 18.22M 18.85M 16.91M 12.52M 6.88M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
421.02M 162.88M 319.84M 153.85M 12.99M 7.4M
Total Assets
981.67M 798.14M 964.8M 754.15M 572.01M 189.19M
Account Payables
3.89M 5.07M 8.6M 8.49M 3.82M 3.04M
Deferred Revenue
n/a n/a n/a n/a n/a 3.64M
Short-Term Debt
1.53M n/a n/a n/a n/a n/a
Other Current Liabilities
21.6M 9.93M 347K 5.82M 5.94M 2.86M
Total Current Liabilities
41.79M 35.59M 27.27M 22.7M 14.32M 14.78M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
3.2M n/a n/a n/a n/a n/a
Total Long-Term Liabilities
358.12M 7.65M 9.6M 9.95M 7.65M 3.05M
Total Liabilities
399.91M 43.24M 36.88M 32.65M 21.97M 17.83M
Total Debt
7.94M 9.02M 10.9M 10.44M 8.26M 3.32M
Book Value
581.76M 754.9M 927.92M 721.5M 550.03M 171.36M
Book Value Per Share
7.34 9.69 13.87 11.92 12.61 4.96
Common Stock
1.6B 1.46B 1.44B 1.07B 783.17M 397.75M
Retained Earnings
-1.25B -899.47M -665.14M -482.75M -357.37M -278.49M
Comprehensive Income
335K -1.61M -77K -3M -990K -990K
Shareholders Equity
581.76M 754.9M 927.92M 721.5M 550.03M 171.36M
Total Investments
386.88M 611.69M 782.23M 663.53M 376.09M 131.99M

© 2026 bestshares.com. All rights reserved.